Bloomberg News

Novo Nordisk Third-Quarter Profit Matches Most Analyst Estimates

October 27, 2011

Oct. 27 (Bloomberg) -- Novo Nordisk A/S, the world’s biggest insulin maker, recorded third-quarter net income of 4.2 billion kroner, compared with an average estimate of 4.22 billion kroner in a Bloomberg survey of 11 analysts.

Novo reported net income of 3.59 billion kroner in the third quarter of 2010. The Bagsvaerd, Denmark-based company published its earnings report in a stock-exchange statement today.

To contact the editor responsible for this story: Christian Wienberg at

The Good Business Issue
blog comments powered by Disqus